ERBB2 and breast cancer: In short, we identified 3 CAF subsets in breast cancer patients and demonstrated enrichment of PLA2G2A+ CAFs in HER2+ tumors, and these may be the main microenvironmental factors that determine the immune infiltration in breast cancer.